Tutorials
Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

ARS 7101.50 (-0.91%) Aug 11
P/E:
24.74
P/B:
4.88
Market Cap:
ARS 21.31T ($ 158.69B)
Enterprise V:
ARS 25.30T ($ 188.41B)
Volume:
2.60K
Avg Vol (2M):
677.00
Also Trade In:
Volume:
2.60K
Market Cap ARS:
21.31T
Market Cap $:
158.69B
PE Ratio:
24.74
Avg Vol (2-Month):
677.00
Enterprise Value ARS:
25.30T
Enterprise Value $:
188.41B
PB Ratio:
4.88
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Bristol-Myers Squibb Co
NAICS : 325412 SIC : 2834
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Description
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Financials (Next Earnings Date:2022-10-27 Est.)

BUE:BMY's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ARS) 5,027,992.256
EPS (TTM) (ARS) 318.295
Beta 0
Volatility % 32.26
14-Day RSI 48.93
14-Day ATR (ARS) 243.344386
20-Day SMA (ARS) 7444.275
12-1 Month Momentum % 90.4
52-Week Range (ARS) 3635 - 8350
Shares Outstanding (Mil) 2,135.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bristol-Myers Squibb Co Filings

Document Form Filing Date
No Filing Data